Clinical Trial Update: Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy [Phase 2]

View source ↗

Summary

Phase II trial evaluating IMC-A12 in mesothelioma patients who had prior chemotherapy has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Mesothelioma
• Pleural Mesothelioma

Drugs mentioned

• IMC-A12 (cixutumumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pleural Mesothelioma, Peritoneal Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2013-05-14